Literature DB >> 15547075

Do statins offer therapeutic potential in inflammatory arthritis?

I B McInnes1, D W McCarey, N Sattar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15547075      PMCID： PMC1754853          DOI： 10.1136/ard.2004.022061

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  33 in total

1.  C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis.

Authors:  T P Zwaka; V Hombach; J Torzewski
Journal:  Circulation       Date:  2001-03-06       Impact factor: 29.690

2.  Extracellular signal-regulated kinase inhibition by statins inhibits neutrophil activation by ANCA.

Authors:  Mira Choi; Susanne Rolle; Madhavi Rane; Hermann Haller; Friedrich C Luft; Ralph Kettritz
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

3.  The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.

Authors:  Sawsan Youssef; Olaf Stüve; Juan C Patarroyo; Pedro J Ruiz; Jennifer L Radosevich; Eun Mi Hur; Manuel Bravo; Dennis J Mitchell; Raymond A Sobel; Lawrence Steinman; Scott S Zamvil
Journal:  Nature       Date:  2002-11-07       Impact factor: 49.962

4.  A novel anti-inflammatory role for simvastatin in inflammatory arthritis.

Authors:  Bernard P Leung; Naveed Sattar; Anne Crilly; Morag Prach; David W McCarey; Helen Payne; Rajan Madhok; Carol Campbell; J Alastair Gracie; Foo Y Liew; Iain B McInnes
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

5.  Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.

Authors:  David W McCarey; Iain B McInnes; Rajan Madhok; Rosie Hampson; Olga Scherbakov; Ian Ford; Hilary A Capell; Naveed Sattar
Journal:  Lancet       Date:  2004-06-19       Impact factor: 79.321

6.  C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

Authors:  Sridevi Devaraj; Dan Yan Xu; Ishwarlal Jialal
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

7.  HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis.

Authors:  Atilla Yilmaz; Christine Reiss; Omeima Tantawi; Alexander Weng; Christian Stumpf; Dorette Raaz; Josef Ludwig; Thomas Berger; Alexander Steinkasserer; Werner G Daniel; Christoph D Garlichs
Journal:  Atherosclerosis       Date:  2004-01       Impact factor: 5.162

8.  Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis.

Authors:  David Hürlimann; Adrian Forster; Georg Noll; Frank Enseleit; Rémy Chenevard; Oliver Distler; Markus Béchir; Lukas E Spieker; Michel Neidhart; Beat A Michel; Renate E Gay; Thomas F Lüscher; Steffen Gay; Frank Ruschitzka
Journal:  Circulation       Date:  2002-10-22       Impact factor: 29.690

9.  The effect of pravastatin on acute rejection after kidney transplantation--a pilot study.

Authors:  S Katznelson; A H Wilkinson; J A Kobashigawa; X M Wang; D Chia; M Ozawa; H P Zhong; M Hirata; A H Cohen; P I Teraski
Journal:  Transplantation       Date:  1996-05-27       Impact factor: 4.939

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245
View more
  8 in total

Review 1.  Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation.

Authors:  Kevin D Deane; Jill M Norris; V Michael Holers
Journal:  Rheum Dis Clin North Am       Date:  2010-05       Impact factor: 2.670

2.  Incident Rheumatoid Arthritis Following Statin Use: From the View of a National Cohort Study in Korea.

Authors:  Mi Jung Kwon; Joo-Hee Kim; Ji Hee Kim; Hye-Rim Park; Nan Young Kim; Sangkyoon Hong; Hyo Geun Choi
Journal:  J Pers Med       Date:  2022-04-01

Review 3.  Statin treatment for rheumatoid arthritis: a promising novel indication.

Authors:  Kosmas I Paraskevas
Journal:  Clin Rheumatol       Date:  2007-12-08       Impact factor: 2.980

4.  The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis.

Authors:  Katherine P Liao; Martin P Playford; Michelle Frits; Jonathan S Coblyn; Christine Iannaccone; Michael E Weinblatt; Nancy S Shadick; Nehal N Mehta
Journal:  J Am Heart Assoc       Date:  2015-01-30       Impact factor: 5.501

5.  Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.

Authors:  Manda V Sasidhar; Sai Krishnaveni Chevooru; Oliver Eickelberg; Hans-Peter Hartung; Oliver Neuhaus
Journal:  PLoS One       Date:  2017-12-18       Impact factor: 3.240

Review 6.  Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19).

Authors:  Ray Subir; Mukherjee Jagat J; Gangopadhyay Kalyan K
Journal:  Diabetes Metab Syndr       Date:  2020-07-11

7.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

8.  The role of simvastatin in the therapeutic approach of rheumatoid arthritis.

Authors:  Lucia Cojocaru; Andrei Constantin Rusali; Cristina Suţa; Anca Mihaela Rădulescu; Maria Suţa; Elvira Craiu
Journal:  Autoimmune Dis       Date:  2013-06-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.